Skip to main content
Equibles

Jeryl Hilleman

CFO

NovoCure Ltd (NVCR)
Omada Health, Inc. (OMDA)

Board Member

Omada Health, Inc. (OMDA)

Board Member

NovoCure Ltd (NVCR)

Equibles does not estimate personal net worth.

Get an email with a short summary when NovoCure Ltd publishes a filing, an earnings call transcript or a press release.

Get NVCR alerts

About Jeryl Hilleman

Jeryl Hilleman is recorded as Board Member at NovoCure Ltd (NVCR) since January 1, 2018, CFO at NovoCure Ltd (NVCR) and Board Member at Omada Health, Inc. (OMDA) since January 1, 2027. The newest filing on record that lists Jeryl Hilleman as CFO and Board Member at NovoCure Ltd (NVCR) is dated April 20, 2026. Omada Health, Inc. reported in an 8-K filed August 6, 2026 that Jeryl Hilleman was appointed Lead Independent Director, effective January 1, 2027. NovoCure Ltd reported in an 8-K filed June 5, 2026 that Jeryl Hilleman was appointed director, effective June 3, 2026. NovoCure Ltd reported in an 8-K filed June 6, 2025 that Jeryl Hilleman was appointed director, effective June 4, 2025. Equibles holds 5 filed executive changes naming Jeryl Hilleman; each is listed under recent activity with its source filing. NovoCure Ltd is classified in the Medical Devices industry within the Healthcare sector. Omada Health, Inc. is classified in the Health Information Services industry within the Healthcare sector. Other leadership on record at NovoCure Ltd includes Asaf Danziger (CEO and Board Member), David Hung (CEO and Board Member), Frank Leonard (CEO and Board Member) and 7 others.

“On August 5, 2026, the Board approved the appointment of Jeryl Hilleman as Lead Independent Director, effective as of the Transition Date.”
Omada Health, Inc. Form 8-K, filed August 6, 2026 · Read the filing
“The Company’s shareholders elected Asaf Danziger, William Doyle, Jeryl Hilleman, David Hung, Frank Leonard, Kinyip Gabriel Leung, Martin Madden, Allyson Ocean, Timothy Scannell, Kristin Stafford and William Vernon as directors, effective immediately, with a term expiring at the annual meeting of shareholders in 2027.”
NovoCure Ltd Form 8-K, filed June 5, 2026 · Read the filing

Affiliation history

Company network

NovoCure Ltd

NVCR

Current role

Medical Devices · Healthcare

CFO, Board Member

2018-01-01–present

Omada Health, Inc.

OMDA

Current role

Health Information Services · Healthcare

Board Member

2027-01-01–present

Leadership on record at NovoCure Ltd

Leadership on record at Omada Health, Inc.

Recent activity